INTERWEST VENTURE MANAGEMENT CO - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 54 filers reported holding XENON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
INTERWEST VENTURE MANAGEMENT CO ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$127,000
-14.2%
8,2930.0%0.05%
+12.8%
Q2 2021$148,0000.0%8,2930.0%0.05%
+20.5%
Q1 2021$148,000
+15.6%
8,2930.0%0.04%
+143.8%
Q4 2020$128,000
+39.1%
8,2930.0%0.02%
-40.7%
Q3 2020$92,000
-11.5%
8,2930.0%0.03%
-68.6%
Q2 2020$104,000
+10.6%
8,2930.0%0.09%
-13.1%
Q1 2020$94,000
-13.8%
8,2930.0%0.10%
+110.6%
Q4 2019$109,000
+45.3%
8,2930.0%0.05%
+62.1%
Q3 2019$75,000
-8.5%
8,2930.0%0.03%
+11.5%
Q2 2019$82,000
-2.4%
8,2930.0%0.03%
-66.2%
Q1 2019$84,000
+61.5%
8,2930.0%0.08%
+5.5%
Q4 2018$52,000
-52.3%
8,2930.0%0.07%
+37.7%
Q3 2018$109,000
+43.4%
8,2930.0%0.05%
+65.6%
Q2 2018$76,000
+230.4%
8,2930.0%0.03%
+220.0%
Q1 2018$23,0000.0%8,2930.0%0.01%
+25.0%
Q4 2017$23,000
-4.2%
8,2930.0%0.01%
+33.3%
Q3 2017$24,000
-7.7%
8,2930.0%0.01%0.0%
Q2 2017$26,000
-21.2%
8,2930.0%0.01%
-14.3%
Q1 2017$33,000
-98.7%
8,293
-97.4%
0.01%
-98.8%
Q4 2016$2,465,000320,0610.59%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders